VIZARSIN 25 mg, film-coated tablets 4 tablets
Active ingredients: Sildenafil citrate, Sildenafil
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet4 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- VIZARSIN 25 mg, comprimés pelliculés
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- 4 plaquette(s) thermoformée(s) PVC-Aluminium de 1 comprimé(s)
- Marketing authorisation holder
- KRKA (SLOVENIE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 24 Jun 2013
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69371748CIP72664508CIP133400926645083Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CITRATE DE SILDÉNAFILcomprimé | 35,12 mg · un comprimé | SA |
| SILDÉNAFILcomprimé | 25 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.